Biologics Contract Development Market 2025 to 2034
Biologics Contract Development Market 2025 to 2034
Biologics Contract Development Market (By Source: Microbial, Mammalian, Others; By Product Service: Cell Line Development, Process Development, Upstream, Others; By Indication: Oncology, Immunological disorders, Cardiovascular disorders, Hematological disorders, Others; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 9.07 Bn
Forecast Year, 2034
USD 23.01 Bn
CAGR, 2025 - 2034
10.90%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global biologics contract development market is set to grow from USD 9.07 billion in 2025 to USD 23.01 billion by 2034, driven by a robust CAGR of 10.9%, fueled by rising outsourcing, biopharmaceutical advancements, and increasing demand for specialized biologics services.
Biologics Contract Development Market Size Analysis
Biologics Contract Development Market Size By Source 2025 to 2034 (USD Billion)
| Source | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Microbial | 2.47 | 2.74 | 3.04 | 3.37 | 3.74 | 4.15 | 4.60 | 5.10 | 5.66 | 6.28 |
| Mammalian | 5.28 | 5.86 | 6.50 | 7.21 | 7.99 | 8.86 | 9.83 | 10.90 | 12.09 | 13.40 |
| Others | 1.31 | 1.46 | 1.62 | 1.79 | 1.99 | 2.20 | 2.44 | 2.71 | 3.01 | 3.33 |
Biologics Contract Development Market Size By Product Service 2025 to 2034 (USD Billion)
| Product Service | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cell Line Development | 2.12 | 2.35 | 2.61 | 2.89 | 3.21 | 3.56 | 3.94 | 4.37 | 4.85 | 5.38 |
| Process Development | 3.25 | 3.60 | 3.99 | 4.43 | 4.91 | 5.44 | 6.04 | 6.70 | 7.43 | 8.24 |
| Upstream | 2.39 | 2.65 | 2.94 | 3.26 | 3.62 | 4.01 | 4.45 | 4.93 | 5.47 | 6.07 |
| Others | 1.31 | 1.46 | 1.62 | 1.79 | 1.99 | 2.20 | 2.44 | 2.71 | 3.00 | 3.33 |
Biologics Contract Development Market Size By Indication 2025 to 2034 (USD Billion)
| Indication | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology | 3.74 | 4.14 | 4.60 | 5.10 | 5.65 | 6.27 | 6.95 | 7.71 | 8.55 | 9.48 |
| Immunological disorders | 1.99 | 2.20 | 2.44 | 2.71 | 3.01 | 3.33 | 3.70 | 4.10 | 4.55 | 5.04 |
| Cardiovascular disorders | 1.28 | 1.42 | 1.58 | 1.75 | 1.94 | 2.15 | 2.39 | 2.65 | 2.94 | 3.26 |
| Hematological disorders | 1.12 | 1.24 | 1.37 | 1.52 | 1.69 | 1.87 | 2.08 | 2.30 | 2.56 | 2.83 |
| Others | 0.94 | 1.05 | 1.16 | 1.29 | 1.43 | 1.58 | 1.76 | 1.95 | 2.16 | 2.40 |
Biologics Contract Development Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 3.39 | 3.76 | 4.17 | 4.62 | 5.12 | 5.68 | 6.30 | 6.99 | 7.75 | 8.59 |
| Europe | 2.44 | 2.71 | 3.01 | 3.33 | 3.70 | 4.10 | 4.55 | 5.04 | 5.59 | 6.20 |
| Asia Pacific | 2.11 | 2.34 | 2.60 | 2.88 | 3.20 | 3.55 | 3.93 | 4.36 | 4.84 | 5.36 |
| Latin America | 0.65 | 0.72 | 0.80 | 0.89 | 0.99 | 1.10 | 1.21 | 1.35 | 1.49 | 1.66 |
| Middle East and Africa | 0.47 | 0.52 | 0.58 | 0.65 | 0.72 | 0.79 | 0.88 | 0.98 | 1.08 | 1.20 |
Biologics Contract Development Market Size to Lead USD 23.01 Billion by 2034
The global biologics contract development market size was estimated at USD 9.07 billion in 2025 and is projected to be worth around USD 23.01 billion by 2034 a CAGR of 10.90%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
